Burden of influenza virus type b and mismatch with the flu vaccine in spain;Impacto del virus gripal tipo b y divergencia con la cepa b incluida en la vacuna antigripal en España1

Revista Espanola de Quimioterapia

Volumn 28, Issue 1, 2015, Pages 39-46

  Eiros Bouza, Jose Ma ^a   Pérez Rubio, Alberto ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; EPIDEMIC; INFLUENZA B; INFLUENZA B VIRUS; INFLUENZA VACCINATION; NONHUMAN; SPAIN; ANTIBODY SPECIFICITY; COST OF ILLNESS; CROSS REACTION; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; SEASON; TREATMENT OUTCOME;

ANTIBODY SPECIFICITY; COST OF ILLNESS; CROSS REACTIONS; HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PUBLIC HEALTH SURVEILLANCE; SEASONS; SPAIN; TREATMENT OUTCOME;

EID: 84942920015     PISSN: 02143429     EISSN: 19889518     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McCullers JA et al. Multiple genotypes of influenza B virus circu­lated between 1979 and 2003. J Virol 2004; 78:12817-28.
2. Peltola V et al. Influenza A and B virus infection in children. Clin Infect Dis 2003; 36:299-305.
3. Hu JJ et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect 2004; 37:95-8.
4. Belshe R.B. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010; 28s:D45-D53.
5. Thompson WW et al. Mortality associated with influenza and respiratory syncitial virus in the United States. JAMA 2003; 289:179-86.
6. Dolin R. The quadrivalent approach to influenza vaccination. J Infect Dis 2013;62:1-43.
7. Reed C et al. Public Health Impact of including two linages of in­fluenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8.
8. Lee BY et al. The economic value of a quadrivalent versus triva­lent influenza vaccine. Vaccine 2012; 30:7443-46.
9. Instituto de Salud Carlos III. Informes anuales y semanales de Vigilancia de la Gripe en España. Sistema de Vigilancia de la Gripe en España. Disponible en: http://cne-gripe-infsemanal.isciii.es y en http://vgripe.isciii.es/. Última visita 08/05/2014.
10. Belshe R et al. Efficacy of live attenuated influenza vaccine in children againts influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-56.
11. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Human vaccines and Immunotherapeutics 2012; 8(1): 81-8.
12. Ficha técnica Fluarix Tetra® . Disponible en http://www.aemps.gob.es/cima/pdfs/es/ft/78568/FT_78568.pdf. Última visita 01/10/2014.
13. Informe del Consejo de Salud Pública de Francia. Haut Con­seil de la santé publique. Utilisation du vaccin contre la grippe saisonnière FluarixTetra® - 23 mai 2014 . Disponible en http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=429. Últi­ma visita 01/10/2014.
14. Informes de la red centinela sanitaria de Castilla y León. Pro­grama de vigilancia de la gripe. Disponible en http://www.salud­castillayleon.es/profesionales/es/centinelas/informes-red-cen­tinela-sanitaria-castilla-leon. Última visita 08/05/2014.
15. Quandelacy TM et al. Age and sex-related Risk factors for Influ­enza associated Mortality in the United States between 1997-2007. Am J Epidemiol 2014; 179: 156-67.
16. Informe de vigilancia de gripe en Canada. Rapport de surveil­lance de la grippe au Canada pour la saison 2013-2014. Dis­ponible en http://www.phac-aspc.gc.ca/fluwatch/index-fra.php (Última visita el 12/05/2014).
17. Valenciano M, Kissling E. I-MOVE case–control study team. Ear­ly estimates of seasonal influenza vaccine effectiveness in Eu­rope: results from the I-MOVE multicentre case–control study, 2012/13. Euro Surveill 2013;18(7):pii=20400. Disponible en: http://www.eurosurveillance.org/images/dynamic/EE/V18N07/art20400.pdf. Última visita 08/05/2014.
18. Jiménez-Jorge S et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012; 17(12). Disponible en: http://www.eurosur­veillance.org/images/dynamic/EE/V17N12/art20129.pdf. Última visita 08/05/2014.
19. Kissling E, Valenciano M. I-MOVE case–control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case–control study, 2011/12. Eurosurveil­lance. 2012;17(15):pii=20146. Disponible en: http://www.euro­surveillance.org/ViewArticle.aspx?ArticleId=20146. Última visita 08/05/2014.
20. Martínez-Baz I et al. Effectiviness of the trivalent influen­za vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health 2013; 13:191.